XLRN - Acceleron Pharma Inc. (XLRN) CEO Habib Dable on Q3 2020 Results - Earnings Call Transcript

Acceleron Pharma Inc. (XLRN) Q3 2020 Earnings Conference Call November 05, 2020 05:00 PM ET Company Participants Jamie Bernard - Associate Director of Investor Relations Habib Dable - Chief Executive Officer Kevin McLaughlin - Chief Financial Officer Jay Backstrom - Head of Research & Development Sujay Kango - Chief Commercial Officer Conference Call Participants Gabe Daoud - Cowen Thomas Deal - Credit Suisse Carter Gould - Barclays Charles Song - SVB Leerink Nicole Gabreski - Piper Sandler Eric Joseph - JPMorgan Yigal Nochomovitz - Citigroup Bikramjot Singh - RBC Capital Markets Presentation Operator Good afternoon, ladies and gentlemen and welcome to the Acceleron Third Quarter 2020 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will be given at that time. As a reminder, this conference call is being recorded. I would now like to hand the

For further details see:

Acceleron Pharma Inc. (XLRN) CEO Habib Dable on Q3 2020 Results - Earnings Call Transcript